AFLD 2012 FFC vs Respondent M50

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M50 for a violation of the Anti-Doping Rules. During a match on April 3, 2011, a sample was taken for doping control purposes. The analysis of the sample showed the presence of prednisone and prednisolone which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list. Prednisone and prednisolone are regarded as specified substances.

History
The respondent confirms the use of prohibited substances, which derive from medicine used to treat rheumatism. There was a therapeutic use exemption (TUE) delivered for this by the Agence Francaise de Lutte contre le Dopage (AFLD). Taking part in matches is only for fun.

Decision
1. The respondent is acquitted.
2. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
10 May 2012
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Exceptional circumstances
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S9. Glucocorticosteroids
Substances
Prednisolone
Prednisone
Medical terms
Therapeutic Use Exemption (TUE)
Document type
Pdf file
Date generated
18 February 2014
Date of last modification
24 February 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin